Company news

Yappli, Inc. (TSE:4168) news

Yappli, Inc. news releases on 6ix. Latest, Jun 10, 2026: GlycoNex Announces Positive Topline Results for Phase III Clinical Trial of Denosumab Biosimilar SPD8

View Yappli, Inc. →

Press releases & updates

GlycoNex Announces Positive Topline Results for Phase III Clinical Trial of Denosumab Biosimilar SPD8

June 9, 2026